Home

Orchid Pharma Ltd EPS

Image

Orchid Pharma Ltd

NSE: ORCHPHARMA

EPS

₹ 19.65

Last updated on: May 28, 2025

Key Highlights

  • The Earning per Share of Orchid Pharma Ltd is ₹ 19.65 as of 28 May 25 .
  • The earning per share of Orchid Pharma Ltd changed from ₹ 1.85 to ₹ 4.4 over 8 quarters. This represents a CAGR of 54.22% .

Historical Earning per Share of Orchid Pharma Ltd

No data available

* All values are in

Company Fundamentals for Orchid Pharma Ltd

Market Cap

3,393 Cr

EPS

19.6

P/E Ratio (TTM)

34.0

P/B Ratio (TTM)

2.7

Day’s High

663.95

Day’s Low

635.55

DTE

0.1

ROE

7.9

52 Week High

1998.0

52 Week Low

635.55

ROCE

7.6

Market Price of Orchid Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Orchid Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
29 May 2025635.55
28 May 2025669
27 May 2025704.2
26 May 2025741
23 May 2025754.4
22 May 2025723.9
21 May 2025741.4
20 May 2025731
19 May 2025759.2
16 May 2025767.65

SWOT Analysis Of Orchid Pharma Ltd

Strength

3

che

Weakness

2

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Orchid Pharma Ltd

Asset Value vs Market Value of Orchid Pharma Ltd

Market Value

3,393

Asset Value

Value addition

3.3 X

791

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Orchid Pharma Ltd3393
Sun Pharmaceutical Industries Ltd399681
Divis Laboratories Ltd176132
Cipla Ltd118622
Torrent Pharmaceuticals Ltd107018
Dr Reddys Laboratories Ltd103748

Historical Market Cap of Orchid Pharma Ltd

No data available

* All values are in crore

Historical Revenue of Orchid Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Orchid Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Orchid Pharma Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Orchid Pharma Ltd News Hub

Orchid Pharma consolidated net profit rises 212.23% in the June 2024 quarter

Net profit of Orchid Pharma rose 212.23% to Rs 29.35 crore in the quarter ended June 2024 as against

Read more

13 Aug 24

Orchid Pharma announces board meeting date

Orchid Pharma will hold a meeting of the Board of Directors of the Company on 12 August 2024. Powere

Read more

10 Aug 24

Orchid Pharma to hold board meeting

Orchid Pharma will hold a meeting of the Board of Directors of the Company on 11 November 2024 Power

Read more

06 Nov 24

Orchid Pharma consolidated net profit rises 37.58% in the September 2024 quarter

Net profit of Orchid Pharma rose 37.58% to Rs 27.24 crore in the quarter ended September 2024 as aga

Read more

11 Nov 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Orchid Pharma Ltd

What is the EPS of Orchid Pharma Ltd stock?

The Earnings Per Share (EPS) of Orchid Pharma Ltd is 19.65. An EPS is the amount of net income attributed to each share of a common stock.

How is Orchid Pharma Ltd EPS calculated?

The EPS of Orchid Pharma Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Orchid Pharma Ltd report its EPS?

Orchid Pharma Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Orchid Pharma Ltd EPS?

Factors that influence the EPS of Orchid Pharma Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Orchid Pharma Ltd EPS growth indicate future performance?

Yes, consistent growth in Orchid Pharma Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions